|
|
Volumn 96, Issue , 2006, Pages 371-391
|
|
Cancer Drug Approval in the United States, Europe, and Japan
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
IMATINIB;
NEW DRUG;
TRASTUZUMAB;
CANCER THERAPY;
DRUG APPROVAL;
DRUG LEGISLATION;
DRUG RESEARCH;
EUROPE;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
HEALTH CARE ORGANIZATION;
HUMAN;
INFORMATION DISSEMINATION;
JAPAN;
PRIORITY JOURNAL;
REVIEW;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUG APPROVAL;
EUROPE;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
JAPAN;
NEOPLASMS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33845189228
PISSN: 0065230X
EISSN: None
Source Type: Book Series
DOI: 10.1016/S0065-230X(06)96012-6 Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
